138 related articles for article (PubMed ID: 21460608)
1. Romiplostim reverts the thrombocytopenia in dengue hemorrhagic fever.
Rodríguez-Mejorada SM; Rosel-Gómez CG; Rosado-Castro RA; Domingo-Padilla MA; Ruiz-Delgado GJ
Hematol Oncol Stem Cell Ther; 2011; 4(1):48-9. PubMed ID: 21460608
[No Abstract] [Full Text] [Related]
2. Romiplostim for chronic lymphocytic leukemia-associated immune thrombocytopenia.
D'Arena G; Cascavilla N
Leuk Lymphoma; 2011 Apr; 52(4):701-4. PubMed ID: 21171868
[No Abstract] [Full Text] [Related]
3. Immune thrombocytopenia and anticoagulation: the role of romiplostim in the early treatment.
Cantoni N; Heizmann M; Bargetzi M
Br J Haematol; 2012 Jun; 157(5):639-41. PubMed ID: 22329466
[No Abstract] [Full Text] [Related]
4. The efficacy of romiplostim in the treatment of severe thrombocytopenia associated to Evans syndrome refractory to rituximab.
Gonzalez-Nieto JA; Martin-Suarez I; Quattrino S; Ortiz-Lopez E; Muñoz-Beamud FR; Colchero-Fernández J; Alcoucer-Diaz MR
Lupus; 2011 Oct; 20(12):1321-3. PubMed ID: 21719526
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia.
Sinisalo M; Sankelo M; Itälä-Remes M
Leuk Lymphoma; 2011 Apr; 52(4):724-5. PubMed ID: 21323511
[No Abstract] [Full Text] [Related]
6. Romiplostim in the management of thrombocytopenia in a patient with autoimmune hepatitis.
Gangireddy VG; Coleman TA; Nabh A; Sridhar S
Dig Dis Sci; 2012 Sep; 57(9):2466-72. PubMed ID: 22828806
[No Abstract] [Full Text] [Related]
7. Romiplostim for the management of perioperative thrombocytopenia.
Al-Samkari H; Marshall AL; Goodarzi K; Kuter DJ
Br J Haematol; 2018 Jul; 182(1):106-113. PubMed ID: 29767837
[TBL] [Abstract][Full Text] [Related]
8. Use of romiplostim allows for hepatitis C therapy in a HIV/HCV coinfected patient.
Taylor N; Melchardt T; Grundbichler M; Strasser M; Egle A; Greil R
Ann Hematol; 2013 Jul; 92(7):1001-2. PubMed ID: 23269533
[No Abstract] [Full Text] [Related]
9. Increased requirement for platelet transfusions concurrent with enhanced bleeding during romiplostim treatment in a patient with thrombocytopenia due to bone marrow failure.
Lotfi R; Moeller P; Schmid M; Schrezenmeier H
Ann Hematol; 2011 Nov; 90(11):1357-9. PubMed ID: 21327404
[No Abstract] [Full Text] [Related]
10. Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial.
Platzbecker U; Sekeres MA; Kantarjian H; Giagounidis A; Mufti GJ; Jia C; Yang AS; Fenaux P
Leukemia; 2014 Dec; 28(12):2418-21. PubMed ID: 25179731
[No Abstract] [Full Text] [Related]
11. Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study.
Newland A; Godeau B; Priego V; Viallard JF; López Fernández MF; Orejudos A; Eisen M
Br J Haematol; 2016 Jan; 172(2):262-73. PubMed ID: 26537623
[TBL] [Abstract][Full Text] [Related]
12. Romiplostim in chronic liver disease with severe thrombocytopenia undergoing an elective invasive procedure.
Castellote J; Girbau A; Arajol C; Xiol X
Rev Esp Enferm Dig; 2011 Oct; 103(10):556. PubMed ID: 22054278
[No Abstract] [Full Text] [Related]
13. Romiplostim resistance in secondary failure of platelet recovery.
DeRemer DL; Katsanevas K; Bradley A; Awan FT
J Oncol Pharm Pract; 2013 Dec; 19(4):369-72. PubMed ID: 23292974
[TBL] [Abstract][Full Text] [Related]
14. Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia.
Berthelot-Richer M; Boilard B; Morin A; Bolduc B; Beauregard P; Kotb R
Transfusion; 2012 Apr; 52(4):739-41. PubMed ID: 22082044
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus erythematosus.
Alkaabi JK; Alkindi S; Riyami NA; Zia F; Balla LM; Balla SM
Lupus; 2012 Dec; 21(14):1571-4. PubMed ID: 23161577
[TBL] [Abstract][Full Text] [Related]
16. The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors.
Al-Samkari H; Marshall AL; Goodarzi K; Kuter DJ
Haematologica; 2018 Apr; 103(4):e169-e172. PubMed ID: 29242295
[No Abstract] [Full Text] [Related]
17. Use of peptide thrombopoietin receptor agonist romiplostim (Nplate) in a case of primary HIV-associated thrombocytopenia.
Aslam MI; Cardile AP; Crawford GE
J Int Assoc Provid AIDS Care; 2014; 13(1):22-3. PubMed ID: 24036490
[TBL] [Abstract][Full Text] [Related]
18. Successful antiviral therapy for hepatitis C virus-induced cirrhosis after an increase in the platelet count with romiplostim: two case reports.
Voican CS; Naveau S; Perlemuter G
Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1455-8. PubMed ID: 22890208
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of romiplostim in treatment of thrombocytopenia in children with Wiskott-Aldrich syndrome.
Khoreva A; Abramova I; Deripapa E; Rodina Y; Roppelt A; Pershin D; Larin S; Voronin K; Maschan A; Novichkova G; Shcherbina A
Br J Haematol; 2021 Jan; 192(2):366-374. PubMed ID: 33131064
[TBL] [Abstract][Full Text] [Related]
20. Severe macrothrombocytopenia with platelet CD9 deficiency responsive to romiplostim.
Seddiq M; Gadgeel M; Persaud Y; Lafferty J; Savaşan S
Br J Haematol; 2020 Aug; 190(4):e239-e242. PubMed ID: 32515038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
